Role of Gd2O3-doped carbon-11-choline-lenvatinib nanoparticles contrast agent PET/CT in the diagnosis of patients with lung cancer.

MLA

Zhou, Tong, et al. “Role of Gd2O3-Doped Carbon-11-Choline-Lenvatinib Nanoparticles Contrast Agent PET/CT in the Diagnosis of Patients with Lung Cancer.” Oncology Letters, vol. 19, no. 2, Feb. 2020, pp. 1117–24. EBSCOhost, https://doi.org/10.3892/ol.2019.11243.

APA

Zhou, T., Hang, D., Li, Y., Zhang, J., Wu, H., Wang, H., Tian, E., & Yan, J. (2020). Role of Gd2O3-doped carbon-11-choline-lenvatinib nanoparticles contrast agent PET/CT in the diagnosis of patients with lung cancer. Oncology Letters, 19(2), 1117–1124. https://doi.org/10.3892/ol.2019.11243

Chicago

Zhou, Tong, Dongfang Hang, Ying Li, Jin Zhang, Huayang Wu, Hongyan Wang, Enbing Tian, and Jun Yan. 2020. “Role of Gd2O3-Doped Carbon-11-Choline-Lenvatinib Nanoparticles Contrast Agent PET/CT in the Diagnosis of Patients with Lung Cancer.” Oncology Letters 19 (2): 1117–24. doi:10.3892/ol.2019.11243.